CC
Live / Applied — Extension of time to oppose received (as of 04 Feb 2026)
What this means for you
Not registered yet, but its 25 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99302309
- Mark type
- Design + words
- Filed
- 25 Jul 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Cy Bates
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Beauty serums; Cosmetic preparations for eyelashes; Eyebrow cosmetics; Non-medicated hair serums; Non-medicated serums for use on eyelashes and eyebrows; Serums for cosmetic purposes; Skin care products, namely, non-medicated skin serum; Facial cream
- Class 005 — Pharmaceuticals: Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers
Owner
- Cellcura Sciences, Inc., Lehi, UT, US
- Cellcura Sciences, Inc., Lehi, UT, US
Prosecution history
- 04 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Dec 2025 — ASSIGNED TO EXAMINER
- 05 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 05 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Jul 2025 — NEW APPLICATION ENTERED